A few weeks ago in Lyon, France, Arthrosurface, along with the other leading orthopaedic device companies, exhibited at the ISAKOS Congress. ISAKOS is a global society of surgeons who are focused on advancing worldwide education, research and patient care in arthroscopy, knee surgery and orthopaedic sports medicine. The Congress meets every other year with locations rotating through the Americas, Europe, Asia and Africa. The next congress will be held in Shanghai in 2017. Surgeon attendees travel from all over the world to see the latest advancements in Orthopaedic Surgery. The majority of these attendees are focused on specific joints (i.e. Knee or Shoulder) and sports medicine in their practices.
ISAKOS has recognized that there is a significant gap between conservative treatments such as Physio-Therapy and anti-inflammatory treatments, and total Joint Replacements. To help address this gap, they are focusing their education efforts on identifying which technologies best match the patients’ disease severity and their activity demands. They found that biology treatments, such as injections, PRP, and stem cells, with different grafting and scaffolding technologies for cartilage regeneration as well as minimally invasive, bone & tissue preserving implant systems. Arthrosurface offers both biology treatments (NanoFx) and Joint Preserving Implants (HemiCAP).
During the Congress, we held a Shoulder HemiCAP Luncheon workshop lead by Dr. Anthony Miniaci from the Cleveland Clinic, that was at full capacity with not one empty seat in the house! We had an excellent booth location, and the products of interested there were NanoFx (micro fracture), the Patello Femoral Wave HemiCAP and the Stemless Total Shoulder.